Nutritional ingredients modulate adipokine secretion and inflammation in human primary adipocytes

Nutrients

Volumn 7, Issue 2, 2015, Pages 865-886

  Romacho, Tania ^a   Glosse, Philipp ^a   Richter, Isabel ^a   Elsen, Manuela ^a   Schoemaker, Marieke H ^b   Van Tol, Eric A ^b   Eckel, Jürgen ^a  

^a LEIBNIZ CENTER FOR DIABETES RESEARCH AT HEINRICH HEINE UNIVERSITY DÜSSELDORF   (Germany)

^b Mead Johnson Nutritionals   (United States)

Author keywords

Adipocytes; Adiponectin; ARA; Casein hydrolysate; DHA; EPA; LC PUFAs; Milk proteins

Indexed keywords

ADIPOCYTOKINE; ARACHIDONIC ACID; CASEIN HYDROLYSATE; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYUNSATURATED FATTY ACID; SYNAPTOTAGMIN I; TUMOR NECROSIS FACTOR ALPHA; CASEIN; CCL2 PROTEIN, HUMAN; MILK PROTEIN; TUMOR NECROSIS FACTOR; UNSATURATED FATTY ACID;

ADIPOCYTE; ADULT; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MIDDLE AGED; NORMAL HUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; UPREGULATION; WESTERN BLOTTING; CELL CULTURE TECHNIQUE; DRUG EFFECTS; METABOLISM;

ADIPOCYTES; ADIPOKINES; CASEINS; CELL CULTURE TECHNIQUES; CHEMOKINE CCL2; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; L-LACTATE DEHYDROGENASE; LEPTIN; MILK PROTEINS; NF-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84921897915     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7020865     Document Type: Article

References (61)

1. Goran, M.I.; Treuth, M.S. Energy expenditure, physical activity, and obesity in children. Pediatr. Clin. North Am.2001, 48, 931–953.
2. Gardner, D.S.; Hosking, J.; Metcalf, B.S.; Jeffery, A.N.; Voss, L.D.; Wilkin, T.J. Contribution of early weight gain to childhood overweight and metabolic health: A longitudinal study (earlybird 36). Pediatrics2009, 123, 67–73.
3. Barker, D.J. Obesity and early life. Obes. Rev.2007, 8(Suppl. 1), 45–49.
4. McMillen, I.C.; Robinson, J.S. Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol. Rev.2005, 85, 571–633.
5. Miralles, O.; Sanchez, J.; Palou, A.; Pico, C. A physiological role of breast milk leptin in body weight control in developing infants. Obesity (Silver Spring)2006, 14, 1371–1377.
6. Power, C.; Parsons, T. Nutritional and other influences in childhood as predictors of adult obesity. Proc. Nutr. Soc.2000, 59, 267–272.
7. Romacho, T.; Elsen, M.; Rohrborn, D.; Eckel, J. Adipose tissue and its role in organ crosstalk. Acta Physiol. (Oxf.)2014, 210, 733–753.
8. Arner, P. Insulin resistance in type 2 diabetes—Role of the adipokines. Curr. Mol. Med.2005, 5, 333–339.
9. Maeda, N.; Shimomura, I.; Kishida, K.; Nishizawa, H.; Matsuda, M.; Nagaretani, H.; Furuyama, N.; Kondo, H.; Takahashi, M.; Arita, Y.; et al. Diet-induced insulin resistance in mice lacking adiponectin/acrp30. Nat. Med.2002, 8, 731–737.
10. Ouchi, N.; Parker, J.L.; Lugus, J.J.; Walsh, K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol.2011, 11, 85–97.
11. Trayhurn, P.; Wood, I.S. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br. J. Nutr.2004, 92, 347–355.
12. Savino, F.; Liguori, S.A.; Fissore, M.F.; Oggero, R. Breast milk hormones and their protective effect on obesity. Int. J. Pediatr. Endocrinol. 2009, 2009, 327505, doi:10.1155/2009/327505.
13. Lillefosse, H.H.; Tastesen, H.S.; Du, Z.Y.; Ditlev, D.B.; Thorsen, F.A.; Madsen, L.; Kristiansen, K.; Liaset, B. Hydrolyzed casein reduces diet-induced obesity in male c57bl/6j mice. J. Nutr.2013, 143, 1367–1375.
14. Brenna, J.T.; Varamini, B.; Jensen, R.G.; Diersen-Schade, D.A.; Boettcher, J.A.; Arterburn, L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am. J. Clin. Nutr.2007, 85, 1457–1464.
15. Birch, E.E.; Garfield, S.; Castaneda, Y.; Hughbanks-Wheaton, D.; Uauy, R.; Hoffman, D. Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum. Dev.2007, 83, 279–284.
16. Flachs, P.; Rossmeisl, M.; Bryhn, M.; Kopecky, J. Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism. Clin. Sci. (Lond.)2009, 116, 1–16.
17. Kopecky, J.; Rossmeisl, M.; Flachs, P.; Kuda, O.; Brauner, P.; Jilkova, Z.; Stankova, B.; Tvrzicka, E.; Bryhn, M. N-3 PUFA: Bioavailability and modulation of adipose tissue function. Proc. Nutr. Soc.2009, 68, 361–369.
18. Kuda, O.; Jelenik, T.; Jilkova, Z.; Flachs, P.; Rossmeisl, M.; Hensler, M.; Kazdova, L.; Ogston, N.; Baranowski, M.; Gorski, J.; et al. N-3 fatty acids and rosiglitazone improve insulin sensitivity through additive stimulatory effects on muscle glycogen synthesis in mice fed a high-fat diet. Diabetologia2009, 52, 941–951.
19. Lorente-Cebrian, S.; Perez-Matute, P.; Martinez, J.A.; Marti, A.; Moreno-Aliaga, M.J. Effects of eicosapentaenoic acid (EPA) on adiponectin gene expression and secretion in primary cultured rat adipocytes. J. Physiol. Biochem.2006, 62, 61–69.
20. Moreno-Aliaga, M.J.; Lorente-Cebrian, S.; Martinez, J.A. Regulation of adipokine secretion by n-3 fatty acids. Proc. Nutr. Soc.2010, 69, 324–332.
21. Oliver, E.; McGillicuddy, F.; Phillips, C.; Toomey, S.; Roche, H.M. The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA. Proc. Nutr. Soc.2010, 69, 232–243.
22. Ailhaud, G.; Guesnet, P.; Cunnane, S.C. An emerging risk factor for obesity: Does disequilibrium of polyunsaturated fatty acid metabolism contribute to excessive adipose tissue development? Br. J. Nutr.2008, 100, 461–470.
23. Flachs, P.; Rossmeisl, M.; Kopecky, J. The effect of n-3 fatty acids on glucose homeostasis and insulin sensitivity. Physiol. Res.2014, 63(Suppl. 1), S93–S118.
24. Kalupahana, N.S.; Claycombe, K.J.; Moustaid-Moussa, N. (n-3) fatty acids alleviate adipose tissue inflammation and insulin resistance: Mechanistic insights. Adv. Nutr.2011, 2, 304–316.
25. Wielinga, P.Y.; Harthoorn, L.F.; Verschuren, L.; Schoemaker, M.H.; Jouni, Z.E.; van Tol, E.A.; Kleemann, R.; Kooistra, T. Arachidonic acid/docosahexaenoic acid-supplemented diet in early life reduces body weight gain, plasma lipids, and adiposity in later life in apoe*3leiden mice. Mol. Nutr. Food Res.2012, 56, 1081–1089.
26. Visser, S.; Slangen, C.J.; Rollema, H.S. Phenotyping of bovine milk proteins by reversed-phase high-performance liquid chromatography. J. Chromatogr.1991, 548, 361–370.
27. Lamers, D.; Schlich, R.; Greulich, S.; Sasson, S.; Sell, H.; Eckel, J. Oleic acid and adipokines synergize in inducing proliferation and inflammatory signalling in human vascular smooth muscle cells. J. Cell. Mol. Med.2011, 15, 1177–1188.
28. Dietze-Schroeder, D.; Sell, H.; Uhlig, M.; Koenen, M.; Eckel, J. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes2005, 54, 2003–2011.
29. Bogin, E.; Ziv, G. Enzymes and minerals in normal and mastitic milk. Cornell Vet. 1973, 63, 666–676.
30. Kim, H.K.; Della-Fera, M.; Lin, J.; Baile, C.A. Docosahexaenoic acid inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 preadipocytes. J. Nutr.2006, 136, 2965–2969.
31. Von Berg, A.; Filipiak-Pittroff, B.; Krämer, U.; Link, E.; Bollrath, C.; Brockow, I.; Koletzko, S.; Grübl, A.; Heinrich, J.; Wichmann, H.-E.; et al. Preventive effect of hydrolyzed infant formulas persists until age 6 years: Long-term results from the German Infant Nutritional Intervention study (GINI). Am. Acad. Allergy Asthma Immunol.2008, 121, 1442–1447.
32. Chatterton, D.E.W.; Nguyen, D.N.; Bering, S.B.; Sangild, P.T. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Int. J. Biochem. Cell Biol.2013, 45, 1730–1747.
33. Mukhopadhya, A.; Noronha, N.; Bahar, B.; Ryan, M.T.; Murray, B.A.; Kelly, P.M.; O’Loughlin, I.B.; O’Doherty, J.V.; Sweeney, T. Anti-inflammatory effects of a casein hydrolysate and its peptide-enriched fractions on TNFα-challenged Caco-2 cells and LPS-challenged porcine colonic explants. Food Sci. Nutr.2014, 2,712–723.
34. Jeffery, A.N.; Murphy, M.J.; Metcalf, B.S.; Hosking, J.; Voss, L.D.; English, P.; Sattar, N.; Wilkin, T.J. Adiponectin in childhood. Int. J. Pediatr. Obes.2008, 3, 130–140.
35. Flexeder, C.; Thiering, E.; Kratzsch, J.; Klumper, C.; Koletzko, B.; Muller, M.J.; Koletzko, S.; Heinrich, J. Is a child’s growth pattern early in life related to serum adipokines at the age of 10 years? Eur. J. Clin. Nutr.2014, 68, 25–31.
36. De Zegher, F.; Sebastiani, G.; Diaz, M.; Sanchez-Infantes, D.; Lopez-Bermejo, A.; Ibanez, L. Body composition and circulating high-molecular-weight adiponectin and IGF-I in infants born small for gestational age: Breast- vs. formula-feeding. Diabetes2012, 61, 1969–1973.
37. Zhang, Q.; Cundiff, J.K.; Maria, S.D.; McMahon, R.J.; Wickham, M.S.; Faulks, R.M.; van Tol, E.A. Differential digestion of human milk proteins in a simulated stomach model. J. Proteome Res.2014, 13, 1055–1064.
38. Nielsen, D.S.; Theil, P.K.; Larsen, L.B.; Purup, S. Effect of milk hydrolysates on inflammation markers and drug-induced transcriptional alterations in cell-based models. J. Anim. Sci.2013, 90(Suppl. 4), 403–405.
39. Phelan, M.; Aherne-Bruce, S.A.; O’Sullivan, D.; FitzGerald, R.J.; O’Brien, N.M. Potential bioactive effects of casein hydrolysates on human cultured cells. Int. Dairy J.2009, 19, 279–285.
40. Phelan, M.; Aisling Aherne, S.; O’Sullivan, D.; FitzGerald, R.J.; O’Brien, N.M. Growth inhibitory effects of casein hydrolysates on human cancer cell lines. J. Dairy Res.2010, 77, 176–182.
41. Ramos-Mandujano, G.; Weiss-Steider, B.; Melo, B.; Cordova, Y.; Ledesma-Martinez, E.; Bustos, S.; Silvestre, O.; Aguiniga, I.; Sosa, N.; Martinez, I.; et al. Alpha-, beta- and kappa-caseins inhibit the proliferation of the myeloid cell lines 32d cl3 and wehi-3 and exhibit different differentiation properties. Immunobiology2008, 213, 133–141.
42. Visser, J.T.; Bos, N.A.; Harthoorn, L.F.; Stellaard, F.; Beijer-Liefers, S.; Rozing, J.; van Tol, E.A. Potential mechanisms explaining why hydrolyzed casein-based diets outclass single amino acid-based diets in the prevention of autoimmune diabetes in diabetes-prone BB rats. Diabetes Metab. Res. Rev.2012, 28, 505–513.
43. Emani, R.; Asghar, M.N.; Toivonen, R.; Lauren, L.; Soderstrom, M.; Toivola, D.M.; van Tol, E.A.; Hanninen, A. Casein hydrolysate diet controls intestinal T cell activation, free radical production and microbial colonisation in nod mice. Diabetologia2014, 56, 1781–1791.
44. Nongonierma, A.B.; FitzGerald, R.J. Dipeptidyl peptidase IV inhibitory and antioxidative properties of milk protein-derived dipeptides and hydrolysates. Peptides2012, 39, 157–163.
45. Perez-Matute, P.; Marti, A.; Martinez, J.A.; Fernandez-Otero, M.P.; Stanhope, K.L.; Havel, P.J.; Moreno-Aliaga, M.J. Eicosapentaenoic fatty acid increases leptin secretion from primary cultured rat adipocytes: Role of glucose metabolism. Am. J. Physiol. Regul. Integr. Comp. Physiol.2005, 288, R1682–R1688.
46. Oster, R.T.; Tishinsky, J.M.; Yuan, Z.; Robinson, L.E. Docosahexaenoic acid increases cellular adiponectin mRNA and secreted adiponectin protein, as well as PPARgamma mRNA, in 3T3-L1 adipocytes. Appl. Physiol. Nutr. Metab.2010, 35, 783–789.
47. Tishinsky, J.M.; Ma, D.W.; Robinson, L.E. Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARgamma-dependent manner in human adipocytes. Obesity (Silver Spring)2011, 19, 262–268.
48. Banga, A.; Unal, R.; Tripathi, P.; Pokrovskaya, I.; Owens, R.J.; Kern, P.A.; Ranganathan, G. Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids. Am. J. Physiol. Endocrinol. Metab.2009, 296, 480–489.
49. Rossi, A.S.; Lombardo, Y.B.; Lacorte, J.M.; Chicco, A.G.; Rouault, C.; Slama, G.; Rizkalla, S.W. Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats. Am. J. Physiol. Regul. Integr. Comp. Physiol.2005, 289, 486–494.
50. Lefils-Lacourtablaise, J.; Socorro, M.; Géloën, A.; Daira, P.; Debard, C.; Loizon, E.; Guichardant, M.; Dominguez, Z.; Vidal, H.; Lagarde, M.; Bernoud-Hubac, N. The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism. PLoS One2013, 8, doi:10.1371/journal.pone.0063997.
51. Wang, Y.; Lam, K.S.L.; Yau, M.; Xu, A. Post-translational modifications of adiponectin: Mechanisms and functional implications. Biochem. J.2008, 409, 623–633.
52. Granado, M.; Fuente-Martin, E.; Garcia-Caceres, C.; Argente, J.; Chowen, J.A. Leptin in early life: A key factor for the development of the adult metabolic profile. Obes. Facts2012, 5, 138–150.
53. Murata, M.; Kaji, H.; Takahashi, Y.; Iida, K.; Mizuno, I.; Okimura, Y.; Abe, H.; Chihara, K. Stimulation by eicosapentaenoic acids of leptin mrna expression and its secretion in mouse 3T3-L1 adipocytes in vitro. Biochem. Biophys. Res. Commun.2000, 270, 343–348.
54. Reseland, J.E.; Haugen, F.; Hollung, K.; Solvoll, K.; Halvorsen, B.; Brude, I.R.; Nenseter, M.S.; Christiansen, E.N.; Drevon, C.A. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J. Lipid Res.2001, 42, 743–750.
55. Maury, E.; Brichard, S.M. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol. Cell. Endocrinol.2010, 314, 1–16.
56. Ouchi, N.; Kihara, S.; Funahashia, T.; Matsuzawaa, Y.; Walsh, K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol.2003, 14, 561–566.
57. Valentine, C.J. Maternal dietary dha supplementation to improve inflammatory outcomes in the preterm infant. Adv. Nutr.2012, 3, 370–376.
58. Sneddon, A.A.; Rayner, D.V.; Mitchell, S.E.; Bashir, S.; Ha, J.H.; Wahle, K.W.; Morris, A.C.; Williams, L.M. Dietary supplementation with conjugated linoleic acid plus n-3 polyunsaturated fatty acid increases food intake and brown adipose tissue in rats. Nutrients2009, 1, 178–196.
59. Titos, E.; Rius, B.; Gonzalez-Periz, A.; Lopez-Vicario, C.; Moran-Salvador, E.; Martinez-Clemente, M.; Arroyo, V.; Claria, J. Resolvin d1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an m2-like phenotype. J. Immunol.2012, 187, 5408–5418.
60. Oh, D.Y.; Talukdar, S.; Bae, E.J.; Imamura, T.; Morinaga, H.; Fan, W.; Li, P.; Lu, W.J.; Watkins, S.M.; Olefsky, J.M. Gpr120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell2010, 142, 687–698.
61. Russell, F.D.; Burgin-Maunder, C.S. Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids. Mar. Drugs2012, 10, 2535–2559.